Citation Impact
Citing Papers
Body Mass Index and Risk of Gastric Cancer: A Meta-analysis of a Population with More Than Ten Million from 24 Prospective Studies
2013
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
2013 Standout
Mechanisms of Resistance to Crizotinib in Patients with ALK Gene Rearranged Non–Small Cell Lung Cancer
2012
Body Mass Index, Hormone Replacement Therapy, and Endometrial Cancer Risk: A Meta-Analysis
2010
Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer
2014
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)
2015
A randomized phase III trial of stereotactic radiosurgery (SRS) versus observation for patients with asymptomatic cerebral oligo-metastases in non-small-cell lung cancer
2014
A meta-analysis of obesity and the risk of pancreatic cancer
2003
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Epothilones – A fascinating family of microtubule stabilizing antitumor agents
2008
Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis
1993 StandoutNature
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study
2007
Inflammation and cancer
2002 StandoutNature
Testicular Germ-Cell Cancer
1997 Standout
Stage I testicular seminoma: results of adjuvant irradiation and surveillance.
1995
The role of diabetes mellitus in the aetiology of renal cell cancer
1999
Second non-germ cell malignancies in patients treated for stage I–II testicular seminoma
1999
Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours
2003 StandoutNature
A view on drug resistance in cancer
2019 StandoutNature
Initial Mass Screening for Colorectal Cancer with Fecal Occult Blood Test: A Prospective Randomized Study at Funen in Denmark
1987
Body Fatness and Cancer — Viewpoint of the IARC Working Group
2016 Standout
Prospective weight change and colon cancer risk in male US health professionals
2008
Suitability of Thoracic Cytology for New Therapeutic Paradigms in Non-small Cell Lung Carcinoma: High Accuracy of Tumor Subtyping and Feasibility of EGFR and KRAS Molecular Testing
2011
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Cancer Incidence in a Population-Based Cohort of Patients Hospitalized With Diabetes Mellitus in Denmark
1997
Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood
1993 Standout
Risk of subsequent non-germ cell cancer after treatment of germ cell cancer in 2006 Norwegian male patients
1997
Anthropometric Characteristics, Physical Activity, and Risk of Non-Hodgkin's Lymphoma Subtypes and B-Cell Chronic Lymphocytic Leukemia: A Prospective Study
2002
Global Cancer Statistics, 2002
2005 Standout
Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study
2016
Epidemiologic and etiologic factors of pancreatic cancer
2002
The biology and management of non-small cell lung cancer
2018 StandoutNature
Abnormal Glucose Metabolism and Pancreatic Cancer Mortality
2000
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
2014 Standout
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
2013 StandoutNature
Treatment of testicular cancer and the development of secondary malignancies.
1995
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Dietary and Nutritional Factors and Pancreatic Cancer: a Case-Control Study Based on Direct Interviews
1998
Excess body weight and the risk of primary liver cancer: An updated meta-analysis of prospective studies
2012
The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease
2000
Changes in Diet and Lifestyle and Long-Term Weight Gain in Women and Men
2011 Standout
Renal-Cell Carcinoma
1996 Standout
Roles of Fas and Fas ligand during mammary gland remodeling
2000
Overall survival with cisplatin–gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)
2010
Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
2016 Standout
Precision Diagnosis and Treatment for Advanced Non–Small-Cell Lung Cancer
2017
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Lung cancer: New biological insights and recent therapeutic advances
2011
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
2007 Standout
Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
2014
A prospective study of obesity and cancer risk (Sweden)
2001
Secondary neoplasms following treatment of malignant germ cell tumors.
1993
Role of Pemetrexed in Sdvanced Non-Small-Cell Lung Cancer: Meta-Analysis of Randomized Controlled Trials, with Histology Subgroup Analysis
2012
Energy balance and cancer: the role of insulin and insulin-like growth factor-I
2001
Obesity, Hypertension, and the Risk of Kidney Cancer in Men
2000
Risk of Second Malignant Neoplasms Among Long-term Survivors of Testicular Cancer
1997
Lung cancer: current therapies and new targeted treatments
2016 Standout
Ten years of anti-vascular endothelial growth factor therapy
2016
Second primary cancer after treatment for cervical cancer. An international cancer registries study
1995
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
2005 Standout
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Second Malignancies following Pure Seminoma
2000
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
2010
Pemetrexed plus Platinum as the First-Line Treatment Option for Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials
2012
Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial
2015
Randomized phase II trial of gefitinib or gemcitabine or docetaxel chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2 or 3 (IFCT-0301 study)
2010
Chronic immune activation and inflammation in the pathogenesis of aids and cancer
2002
Epidemiology of Lung Cancer
2013
Physical activity, anthropometric factors and risk of pancreatic cancer: Results from the Canadian enhanced cancer surveillance system
2001
Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin
2015
C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease
2004 Standout
Hereditary nonpolyposis colorectal cancer (Lynch syndromes I & II)
1991
Height, Weight, Weight Change, and Ovarian Cancer Risk in the Netherlands Cohort Study on Diet and Cancer
2003
Overweight and obesity in adults and risk of renal cell carcinoma in Canada
2003
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
2007 Standout
Inflammation and cancer: back to Virchow?
2001 Standout
Body size and ovarian cancer: case–control study and systematic review (Australia)
2001
Lifestyle issues and genitourinary tumours
2004
Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial
2012
The renal risks of smoking
1997
Physical Activity, Obesity, Height, and the Risk of Pancreatic Cancer
2001
Obesity and cancer risk among white and black United States veterans
2004
Maintenance Therapy With Continuous or Switch Strategy in Advanced Non-small Cell Lung Cancer
2011
Maintenance bevacizumab–pemetrexed after first-line cisplatin–pemetrexed–bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trial
2014
Hormonal Etiology of Epithelial Ovarian Cancer, With a Hypothesis Concerning the Role of Androgens and Progesterone
1998
Overweight as an avoidable cause of cancer in Europe
2001
Nutrition and renal cell cancer
1996
Association of Obesity and Cancer Risk in Canada
2004
Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy
2012 Standout
Mortality and cancer incidence following radiotherapy for seminoma of the testis
1994
Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial
2012
The TNF and TNF Receptor Superfamilies
2001 Standout
Cancer-related inflammation
2008 StandoutNature
Hepatocellular Carcinoma
2011 Standout
A systematic review of the clinical effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer
2015
Obesity and renal cell cancer – a quantitative review
2001
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study
2010
Familial testicular cancer and second primary cancers in testicular cancer patients by histological type
2001
Therapy-associated Solid Tumors
2002
Single agent maintenance therapy for advanced stage non-small cell lung cancer: A meta-analysis
2012
Physical Activity and Breast Cancer
2006
Pemetrexed-based chemotherapy in patients with advanced, ALK-positive non-small cell lung cancer
2012
Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults
2003 Standout
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
Autochthonous tumors driven by Rb1 loss have an ongoing requirement for the RBP2 histone demethylase
2018 StandoutNobel
Micelle-Encapsulated Quantum Dot-Porphyrin Assemblies as in Vivo Two-Photon Oxygen Sensors
2015 StandoutNobel
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
2018 Standout
Drug Discovery and Natural Products: End of an Era or an Endless Frontier?
2009 StandoutScience
Body mass index and the risk of cancers of the gastric cardia and distal stomach in Shanghai, China.
1997
Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene
2005
Body mass index, height, and the risk of ovarian cancer mortality in a prospective cohort of postmenopausal women.
2002
Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer.
1995
Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial
2012
Prognostic Factors for Relapse in Stage I Seminoma Managed by Surveillance: A Pooled Analysis
2002
Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States.
2001
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Symptom Control and Quality of Life in LUX-Lung 3: A Phase III Study of Afatinib or Cisplatin/Pemetrexed in Patients With Advanced Lung Adenocarcinoma With EGFR Mutations
2013
Pemetrexed versus erlotinib in pretreated patients with advanced non–small cell lung cancer: A Hellenic Oncology Research Group (HORG) randomized phase 3 study
2013
Anti-Angiogenics: Current Situation and Future Perspectives
2018
Obesity as a risk factor for certain types of cancer
1998
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
Integration of Molecular Profiling into the Lung Cancer Clinic
2009
Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
1996 StandoutNobel
Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study
2009
Obesity and risk of renal cell cancer.
1996
Metabolic reprogramming and cancer progression
2020 StandoutScience
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
Optimal Planning Target Volume for Stage I Testicular Seminoma: A Medical Research Council Randomized Trial
1999
Hazards of heavy metal contamination
2003 Standout
Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders.
1997
Global cancer statistics, 2012
2015 Standout
The Differential Efficacy of Pemetrexed According to NSCLC Histology: A Review of Two Phase III Studies
2009
Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
2015
PARAMOUNT: Final Overall Survival Results of the Phase III Study of Maintenance Pemetrexed Versus Placebo Immediately After Induction Treatment With Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non–Small-Cell Lung Cancer
2013
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
2009 StandoutScience
Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer
2013
Randomized Phase III Trial of Maintenance Bevacizumab With or Without Pemetrexed After First-Line Induction With Bevacizumab, Cisplatin, and Pemetrexed in Advanced Nonsquamous Non–Small-Cell Lung Cancer: AVAPERL (MO22089)
2013
Works of Anders Mellemgaard being referenced
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
Analysis of patient-reported outcomes from the LUME-Lung 1 trial: A randomised, double-blind, placebo-controlled, Phase III study of second-line nintedanib in patients with advanced non-small cell lung cancer
2014
Age at first birth, parity and risk of breast cancer: A meta‐analysis of 8 studies from the nordic countries
1990
Risk factors for renal‐cell carcinoma in Denmark. III. Role of weight, physical activity and reproductive factors
1994
Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial
2014
International renal-cell-cancer study. VI. The role of medical and family history
1996
Risk Factors for Renal Cell Carcinoma in Denmark: Role of Medication and Medical History
1994
Dietary risk factors for renal cell carcinoma in Denmark
1996
International renal‐cell cancer study. I. Tobacco use
1995
International renal cell cancer study. VII. role of diet
1996
International renal‐cell cancer study. IV. Occupation
1995
Increased Risk of Renal Cell Carcinoma Among Obese Women
1991
International renal‐cell cancer study. II. Analgesics
1995
Incidence of second primary cancer following testicular cancer
1993
Obesity and cancer risk: a danish record-linkage study
1994
International renal‐cell cancer study. III. Role of weight, height, physical activity, and use of amphetamines
1995
Increased incidence of sarcoma in patients treated for testicular seminoma
1993
International renal‐cell cancer study. VIII. Role of diuretics, other anti‐hypertensive medications and hypertension
1995
Risk factors for renal cell carcinoma in Denmark. I. Role of socioeconomic status, tobacco use, beverages, and family history
1994
International renal‐cell cancer study. V. Reproductive factors, gynecologic operations and exogenous hormones
1995
Review of Thyroid Cancer Cases Among Patients with Previous Benign Thyroid Disorders
2000
Metachronous colorectal carcinoma
1990
[Colorectal cancer in Denmark 1943-1982. Cancer statistics no. 16].
1987
[Increased incidence of sarcoma in patients treated for seminoma].
1994
Efficacy and safety of patupilone in non-small cell lung cancer (NSCLC): A phase I/II trial
2006
International renal‐cell‐cancer study. VI. The role of medical and family history
1996